FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591168929> ?p ?o ?g. }

• W2591168929 abstract "Abstract Abstract 2240 Background and Rationale: Vasoocclusive crises are a major hallmark of sickle cell disease (SCD) pathobiology; experimental evidence suggests that SCD vasoocclusion can be triggered by the increased adhesion of white blood cells, including monocytes, to the microvascular endothelium. Pro-coagulant activity of Tissue Factor, the trigger of blood coagulation, is heightened in the blood of patients with SCD. We recently reported that, compared to full length Tissue Factor (flTF), alternatively spliced Tissue Factor (asTF) acts as a very potent inducer of cell adhesion molecules E-selectin, VCAM-1, and ICAM-1 on microvascular endothelial cells, thereby raising the possibility that asTF may promote monocyte adhesion to the endothelium in vivo (Srinivasan et al, J Thromb Haemost 2011). Analogously to flTF, asTF is continuously present in circulation. Currently, no asTF-specific assay exists that can reliably detect asTF protein in plasma, and no data is available on the levels of asTF in the plasma of patients with SCD. We sought to develop monoclonal antibodies suitable for asTF-specific enzyme-linked immunosorbent assay (ELISA), to evaluate the levels of plasma asTF in SCD patients and age/gender matched healthy subjects. Methods: Two rabbit monoclonal antibodies were raised and characterized: i) antibody RabMab-95 recognizing amino acid residues 81–95 of mature asTF; ii) antibody RabMab-1 recognizing the last 11 amino acid residues of the asTF's unique C-terminus. By western blotting, both RabMab's recognized a) recombinant asTF produced in E. coli, b) eukaryotic asTF expressed in HEK293 cells using an inducible promoter system, and c) native asTF constitutively expressed in human pancreatic adenocarcinoma cell lines, with high specificity and sensitivity. In a sandwich ELISA of platelet poor plasma (PPP) samples, RabMab-95 was used as the capture antibody and horseradish peroxidase-conjugated RabMab-1 as the detection antibody; conventional blocking, sample incubation, and substrate development techniques were used. In addition, levels of flTF in PPP samples were assessed using ZYMUTEST Tissue Factor kit (RK035A, HYPHEN BioMed). Results: The SCD cohort comprised 16 pediatric and adult patients (10 females and 6 males, average age: 28.25±11.3 years); in the healthy subject cohort (n=17, 10 females and 7 males), the average age was 26.6±6.7 years. 14 out of 16 SCD patients had detectable levels of asTF, ranging from 25 pg/mL to 38,350 pg/mL (average: 5,323±9,934 pg/mL); in contrast, only 2 out of 17 healthy subjects had detectable levels of asTF: one PPP sample had 650 pg/ml and the other, 1,883 pg/mL (p=0.0397, SCD vs healthy subjects). The adult (>20 y.o., n= 10, average age: 35.2±7.8 years) and the pediatric (≤20 y.o., n=6, average age: 16.7±3.6 years) SCD sub-cohorts had average asTF values of 8,319±11,738 pg/mL and 329±446 pg/mL, respectively; while the difference between the adult SCD sub-cohort and the age-matched healthy subject sub-cohort was statistically significant (p=0.0337, adult SCD vs age-matched healthy subjects), there was a trend toward statistical significance in the pediatric asTF sub-cohort when compared to age-matched healthy subjects (p=0.1004, pediatric SCD vs age-matched healthy subjects). The levels of flTF in SCD plasma ranged from less than 1 pg/mL to 105 pg/mL (8 out of 16 patients), and did not correlate with asTF levels. Conclusions: We have developed a monoclonal ELISA for specific detection of asTF in human PPP. Our findings indicate that adult as well as pediatric SCD patients have heightened levels of asTF protein in circulation. Importantly, in ∼50% of SCD patients the levels of plasma asTF were in the range vastly exceeding the levels previously reported for any form of blood borne TF, likely sufficient to trigger a physiologically significant increase in leukocyte adhesion to the endothelium. Examination of circulating asTF levels in larger cohorts of pediatric and adult patients with SCD is thus highly warranted. Disclosures: No relevant conflicts of interest to declare." @default.
• W2591168929 created "2017-03-03" @default.
• W2591168929 creator A5022451205 @default.
• W2591168929 creator A5046314701 @default.
• W2591168929 creator A5047649483 @default.
• W2591168929 date "2011-11-18" @default.
• W2591168929 modified "2023-09-26" @default.
• W2591168929 title "Alternatively Spliced Tissue Factor (asTF) Is Elevated in the Plasma of Patients with Sickle Cell Disease: Pilot Studies Performed Using a Novel asTF-Specific ELISA" @default.
• W2591168929 doi "https://doi.org/10.1182/blood.v118.21.2240.2240" @default.
• W2591168929 hasPublicationYear "2011" @default.
• W2591168929 type Work @default.
• W2591168929 sameAs 2591168929 @default.
• W2591168929 citedByCount "2" @default.
• W2591168929 countsByYear W25911689292012 @default.
• W2591168929 countsByYear W25911689292021 @default.
• W2591168929 crossrefType "journal-article" @default.
• W2591168929 hasAuthorship W2591168929A5022451205 @default.
• W2591168929 hasAuthorship W2591168929A5046314701 @default.
• W2591168929 hasAuthorship W2591168929A5047649483 @default.
• W2591168929 hasConcept C126322002 @default.
• W2591168929 hasConcept C153911025 @default.
• W2591168929 hasConcept C159654299 @default.
• W2591168929 hasConcept C186738567 @default.
• W2591168929 hasConcept C203014093 @default.
• W2591168929 hasConcept C2778382381 @default.
• W2591168929 hasConcept C542903549 @default.
• W2591168929 hasConcept C71924100 @default.
• W2591168929 hasConcept C86803240 @default.
• W2591168929 hasConceptScore W2591168929C126322002 @default.
• W2591168929 hasConceptScore W2591168929C153911025 @default.
• W2591168929 hasConceptScore W2591168929C159654299 @default.
• W2591168929 hasConceptScore W2591168929C186738567 @default.
• W2591168929 hasConceptScore W2591168929C203014093 @default.
• W2591168929 hasConceptScore W2591168929C2778382381 @default.
• W2591168929 hasConceptScore W2591168929C542903549 @default.
• W2591168929 hasConceptScore W2591168929C71924100 @default.
• W2591168929 hasConceptScore W2591168929C86803240 @default.
• W2591168929 hasLocation W25911689291 @default.
• W2591168929 hasOpenAccess W2591168929 @default.
• W2591168929 hasPrimaryLocation W25911689291 @default.
• W2591168929 hasRelatedWork W1982140137 @default.
• W2591168929 hasRelatedWork W1998644377 @default.
• W2591168929 hasRelatedWork W2028511021 @default.
• W2591168929 hasRelatedWork W2082203090 @default.
• W2591168929 hasRelatedWork W2083638224 @default.
• W2591168929 hasRelatedWork W2359581123 @default.
• W2591168929 hasRelatedWork W2394152633 @default.
• W2591168929 hasRelatedWork W2396702737 @default.
• W2591168929 hasRelatedWork W2410498999 @default.
• W2591168929 hasRelatedWork W2551626993 @default.
• W2591168929 hasRelatedWork W2556011337 @default.
• W2591168929 hasRelatedWork W2561963024 @default.
• W2591168929 hasRelatedWork W2568234780 @default.
• W2591168929 hasRelatedWork W2581077917 @default.
• W2591168929 hasRelatedWork W2914324306 @default.
• W2591168929 hasRelatedWork W2919590371 @default.
• W2591168929 hasRelatedWork W3091130755 @default.
• W2591168929 hasRelatedWork W3097677949 @default.
• W2591168929 hasRelatedWork W3196859182 @default.
• W2591168929 hasRelatedWork W48987469 @default.
• W2591168929 isParatext "false" @default.
• W2591168929 isRetracted "false" @default.
• W2591168929 magId "2591168929" @default.
• W2591168929 workType "article" @default.